Craig Kevin James
Chief Medical Officer
Craig Kevin James has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, Craig Kevin James is listed as Chief Medical Officer at AtaiBeckley Inc. Inside the rolling window, Craig Kevin James reported no open-market purchases and 3 open-market sales totaling $760K in ATAI. The largest disclosed transaction in the window is a sale of 100,000 ATAI shares on Mar 20, 2026, worth $355K.
Companies traded
Other insiders at ATAI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$760K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Craig Kevin James made?
Craig Kevin James has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does Craig Kevin James trade?
Craig Kevin James has filed SEC Form 4 disclosures for 1 company, including ATAI.
When was Craig Kevin James's most recent SEC Form 4 filing?
Craig Kevin James's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is Craig Kevin James's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Craig Kevin James is listed as Chief Medical Officer.
What is Craig Kevin James's total buy and sell value in the current window?
Inside the rolling retention window, Craig Kevin James bought $0 and sold $760K based on SEC Form 4 filings.
What was Craig Kevin James's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 100,000 ATAI shares on 2026-03-20, worth $355K, per SEC Form 4 filings.